Capital AtlasCapital Atlas
Start my raise
Just Raised→Funds→VC MCP→Pricing→For VCs→Log in→
Just RaisedFundsVC MCPPricingFor VCs
Log inStart my raise
Capital AtlasCapital Atlas
Start my raise
Just Raised→Funds→VC MCP→Pricing→For VCs→Log in→
Just RaisedFundsVC MCPPricingFor VCs
Log inStart my raise
Funds/Latin America & Caribbean/23S Capital

23S Capital

Private Equity FirmSao Paulo, Brazil·Founded 2022·23scapital.com

Est. dry powder

$232.1M

Raised, not yet invested

AUM

—

Not reported

Latest fund

—

Spalla, size not reported

Est. cheque size

$6.8M–$33.8M

From fund sizes

Deals, last 12 months

—

Not reported

About 23S Capital

23S Capital is a Brazil-based private equity firm that focuses on growth opportunities in technology, education, and other diversified industries, investing globally, primarily in Brazil.

Type
Private Equity Firm
Headquarters
Sao Paulo, Sao Paulo, Brazil
Stages
Series C
Est. cheque size
$6.8M–$33.8M
Sectors
Diversified
Strategies
Growth

Where they invest

From deals and portfolio companies on record

Most frequent rounds

  • Series C1

Across 1 deals

Portfolio sectors

  • Financial Services1

Across 1 companies

Portfolio countries

  • Brazil1

Across 1 companies

Recent investments

Newest 1 of 1

DateCompanyRoundAmountCo-investors
  1. Oct 2024

    Asaas Gestão Financeira S.A.

    Oct 2024 · Series C

    Series C$150.2MEndeavor Catalyst, Bond, Softbank Latin America Ventures

Offices

1 location

  • Sao Paulo, Sao Paulo, BrazilHQ

Ask your agent

“Is 23S Capital a fit for our series c round, and who should we email there?”

Connect Claude, ChatGPT or Cursor to Capital Atlas and ask about any fund.

Connect your agent

Work at 23S Capital?

Claim this profile to correct your thesis and cheque size, and choose how founders reach you.

Claim this profile

Questions about 23S Capital

How much does 23S Capital invest per deal?

Based on the size of its funds, 23S Capital writes estimated cheques of $6.8M–$33.8M. Lead cheques usually sit at the top of that range and follow-on cheques lower.

What stages does 23S Capital invest in?

23S Capital has invested at Series C. Its most frequent rounds on record are Series C.

How much capital does 23S Capital have left to invest?

23S Capital has an estimated $232.1M in dry powder: capital it has raised but not yet invested.

Similar investors in Latin America & Caribbean

Crescera CapitalBrazil · Cheque $231K–$3.4M$1.2B dry powderKaszek VenturesBrazil · Cheque $2M–$23.8M$448M dry powderFondo de Fondos

Capital Atlas

Capital Atlas finds the investors deploying capital into companies like yours, from your AI agent or the web.

The Capital Atlas newsletter

Who's deploying, who's leading rounds, and what investors want to see. Unsubscribe any time. See our privacy policy.

Resources

  • Funds
  • Lists
  • New rounds
  • Startups
  • Map

Founders

  • I'm raising
  • Ready to raise
  • VC MCP
  • For agents
  • Docs
  • Log in

Company

  • For VCs
  • About
  • Pricing
  • Contact
  • Terms
  • Privacy
© 2026 Capital AtlasBuilt by Overdrive
TermsPrivacy
What has 23S Capital invested in recently?

Recent investments include Asaas Gestão Financeira S.A..

Where is 23S Capital based?

23S Capital is headquartered in Sao Paulo, Brazil.

How do I contact 23S Capital?

Partner names, emails and LinkedIn profiles for 23S Capital are on the Capital Atlas Pro and Team plans, which also draft outreach and track replies. Check the stages and cheque size above first, so you pitch a firm that fits your round.

Mexico · Cheque $270K–$1.4M
$124.7M dry powder
LIV CapitalMexico · Cheque $110K–$1.7M$123M dry powder
Anti FundPuerto Rico · Cheque $200K–$10.9M$100.4M dry powder
UpstreamBrazil · Cheque $1.5M–$7.5M$84M dry powder
New startup roundsNew rounds
  • UniX AISeed
  • Phrontline BiopharmaSeries A
  • QQingkui ZhizaoSeries A
  • AAozidaSeries D
  • MirendilSeries A
  • UFORCESeries A
  • Q-CTRLSeries C
  • NeurosterixSeries B
  • DatabentoSeries C
  • FFushi TechnologySeries C
  • YYilian Nuclear MedicineSeries A
  • EEli RadiopharmaSeries A
  • Orakl OncologySeries A
  • SE3Series A
  • LuminalSeries A
  • Hatz AISeries A
  • UniX AISeed
  • Phrontline BiopharmaSeries A
  • QQingkui ZhizaoSeries A
  • AAozidaSeries D
  • MirendilSeries A
  • UFORCESeries A
  • Q-CTRLSeries C
NeurosterixSeries B
  • DatabentoSeries C
  • FFushi TechnologySeries C
  • YYilian Nuclear MedicineSeries A
  • EEli RadiopharmaSeries A
  • Orakl OncologySeries A
  • SE3Series A
  • LuminalSeries A
  • Hatz AISeries A